Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 501-510 of 11953

Edit search filters
  1. Emricasan, An Oral Caspase Inhibitor, In Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis And Severe Portal Hypertension

    Rochester, MN

  2. A Study For Patients Who Completed VITALITY-ALS (CY 4031) VIGOR-ALS

    Jacksonville, FL

  3. A Single Patient Treatment Use Of UX007 For Adult Malonyl-coA Decarboxylase Deficiency

    Rochester, MN

  4. DSC-MRI In Measuring Relative Cerebral Blood Volume For Early Response To Bevacizumab In Patients With Recurrent Glioblastoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Controlled Clinical Study Of Dupilumab In Patients With Nasal Polyps

    Rochester, MN

  6. A Study Of The Effectiveness Of EXPAREL For Pain Control In Adult Subjects Undergoing Open Lumbar Spinal Fusion Surgery

    Rochester, MN

  7. A Study Of LY2951742 For Patients With Episodic Cluster Headaches

    Jacksonville, FL

  8. A Study Of The Safety, Tolerability, And Effectiveness Of GS-9674 For Adults With Primary Sclerosing Cholangitis Without Cirrhosis

    Scottsdale/Phoenix, AZ

  9. A Study Of Atrial Cardiopathy And Antithrombotic Drugs In Prevention After Cryptogenic Stroke

    Jacksonville, FL

  10. CC-220-MM-001: A Phase 1b/2a Multicenter, Open-Label, Dose-Escalation Study To Determine The Maximum Tolerated Dose, Assess The Safety, Tolerability, Pharmacokinetics And Efficacy Of CC-220 As Monotherapy And In Combination With Other Treatments In Subjects With Multiple Myeloma

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer